Search details
1.
Satisfaction and experiences of patients taking fingolimod and involved in a pharmacy-based patient support program in Switzerland - a qualitative study.
BMC Health Serv Res
; 20(1): 425, 2020 May 14.
Article
in English
| MEDLINE | ID: mdl-32410681
2.
[Neurology]. / Neurologie.
Rev Med Suisse
; 14(588-589): 58-61, 2018 Jan 10.
Article
in French
| MEDLINE | ID: mdl-29337452
3.
Progressive multifocal leukoencephalopathy in two natalizumab-treated stepsisters: An intriguing coincidence.
Mult Scler
; 23(2): 300-303, 2017 Feb.
Article
in English
| MEDLINE | ID: mdl-28165319
4.
Increased ex vivo antigen presentation profile of B cells in multiple sclerosis.
Mult Scler
; 23(6): 802-809, 2017 05.
Article
in English
| MEDLINE | ID: mdl-27503907
5.
[Neurology]. / Neurologie.
Rev Med Suisse
; 13(544-545): 79-83, 2017 Jan 11.
Article
in French
| MEDLINE | ID: mdl-28703543
6.
Automated detection of white matter and cortical lesions in early stages of multiple sclerosis.
J Magn Reson Imaging
; 43(6): 1445-54, 2016 06.
Article
in English
| MEDLINE | ID: mdl-26606758
7.
Serum neurofilament light chain in early relapsing remitting MS is increased and correlates with CSF levels and with MRI measures of disease severity.
Mult Scler
; 22(12): 1550-1559, 2016 10.
Article
in English
| MEDLINE | ID: mdl-26754800
8.
Multicontrast connectometry: a new tool to assess cerebellum alterations in early relapsing-remitting multiple sclerosis.
Hum Brain Mapp
; 36(4): 1609-19, 2015 Apr.
Article
in English
| MEDLINE | ID: mdl-25421928
9.
Interleukin-22 is increased in multiple sclerosis patients and targets astrocytes.
J Neuroinflammation
; 12: 119, 2015 Jun 16.
Article
in English
| MEDLINE | ID: mdl-26077779
10.
A phase IIa randomised clinical study of GNbAC1, a humanised monoclonal antibody against the envelope protein of multiple sclerosis-associated endogenous retrovirus in multiple sclerosis patients.
Mult Scler
; 21(7): 885-93, 2015 Jun.
Article
in English
| MEDLINE | ID: mdl-25392325
11.
[News in neurology 2014]. / Neurologie.
Rev Med Suisse
; 11(456-457): 91-6, 2015 Jan 14.
Article
in French
| MEDLINE | ID: mdl-25799659
12.
Natalizumab treatment alters the expression of T-cell trafficking marker LFA-1 α-chain (CD11a) in MS patients.
Mult Scler
; 20(7): 837-42, 2014 06.
Article
in English
| MEDLINE | ID: mdl-24258149
13.
HLA-B7-restricted EBV-specific CD8+ T cells are dysregulated in multiple sclerosis.
J Immunol
; 188(9): 4671-80, 2012 May 01.
Article
in English
| MEDLINE | ID: mdl-22461701
14.
[News in neurology 2013]. / Neurologie.
Rev Med Suisse
; 10(412-413): 78-81, 2014 Jan 15.
Article
in French
| MEDLINE | ID: mdl-24558905
15.
Principal components of functional connectivity: a new approach to study dynamic brain connectivity during rest.
Neuroimage
; 83: 937-50, 2013 Dec.
Article
in English
| MEDLINE | ID: mdl-23872496
16.
MOBP-specific cellular immune responses are weaker than MOG-specific cellular immune responses in patients with multiple sclerosis and healthy subjects.
Neurol Sci
; 34(4): 539-43, 2013 Apr.
Article
in English
| MEDLINE | ID: mdl-22752855
17.
Classifying minimally disabled multiple sclerosis patients from resting state functional connectivity.
Neuroimage
; 62(3): 2021-33, 2012 Sep.
Article
in English
| MEDLINE | ID: mdl-22677149
18.
[Multiple sclerosis: beyong first line therapies]. / Sclérose en plaques: au-delà des traitements de première ligne.
Rev Med Suisse
; 8(339): 946-9, 2012 May 02.
Article
in French
| MEDLINE | ID: mdl-22675826
19.
Intrathecal immune responses to EBV in early MS.
Eur J Immunol
; 40(3): 878-87, 2010 Mar.
Article
in English
| MEDLINE | ID: mdl-20017197
20.
Longitudinal analysis of safety and medication adherence of patients in the Fingolimod patient support program: a real-world observational study.
Sci Rep
; 11(1): 4107, 2021 02 18.
Article
in English
| MEDLINE | ID: mdl-33603005